Gray baby syndrome

From Wikipedia, the free encyclopedia

Gray baby syndrome
Classification & external resources
ICD-10 P93.
ICD-9 779.4
MedlinePlus 007049

Gray baby syndrome (also termed Gray or Grey syndrome) is a rare but serious side effect that occurs in newborn infants (especially premature babies) following the intravenous administration of the antibiotic chloramphenicol.[1]

Contents

[edit] Pathophysiology

Newborn infants are predisposed to this condition because they do not yet have fully functional liver enzymes, nor do they have enough enzymes to handle the drug.[2]

[edit] Clinical features

Toxic levels of chloramphenicol after 2–9 days result in:

[edit] Treatment

Chloramphenicol therapy is discontinued immediately; exchange transfusion may be required to remove the drug.

[edit] Prevention

The condition can be prevented by using chloramphenicol at the recommended doses and monitoring blood levels.[3][4][5]

[edit] Footnotes

  1. ^ McIntyre J, Choonara I (2004). "Drug toxicity in the neonate.". Biol Neonate 86 (4): 218-21. PMID 15249753. 
  2. ^ Piñeiro-Carrero V, Piñeiro E (2004). "Liver.". Pediatrics 113 (4 Suppl): 1097-106. PMID 15060205. 
  3. ^ Feder H (1986). "Chloramphenicol: what we have learned in the last decade.". South Med J 79 (9): 1129-34. PMID 3529436. 
  4. ^ Mulhall A, de Louvois J, Hurley R (1983). "Chloramphenicol toxicity in neonates: its incidence and prevention." (Scanned copy & PDF). Br Med J (Clin Res Ed) 287 (6403): 1424-7. PMID 6416440. 
  5. ^ Forster J, Hufschmidt C, Niederhoff H, Künzer W (1985). "[Need for the determination of chloramphenicol levels in the treatment of bacterial-purulent meningitis with chloramphenicol succinate in infants and small children]". Monatsschr Kinderheilkd 133 (4): 209-13. PMID 4000136. 
In other languages